TXMD - TherapeuticsMD, Inc.
IEX Last Trade
1.095
-0.065 -5.936%
Share volume: 0
Last Updated: Thu 26 Dec 2024 09:17:13 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$1.16
-0.07
-5.60%
Fundamental analysis
23%
Profitability
23%
Dept financing
24%
Liquidity
75%
Performance
10%
Performance
5 Days
1.38%
1 Month
-20.71%
3 Months
-32.72%
6 Months
-35.46%
1 Year
-54.87%
2 Year
-78.81%
Key data
Stock price
$1.10
DAY RANGE
$1.11 - $1.73
52 WEEK RANGE
$1.14 - $2.75
52 WEEK CHANGE
-$52.96
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Mark A. Glickman
Region: US
Website: therapeuticsmd.com
Employees: 420
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: therapeuticsmd.com
Employees: 420
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone. It also manufactures and distributes branded and generic prescription prenatal vitamins.
Recent news